title: A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
authors.affiliation: Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, Spain; Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Catalonia, Spain.
authors.forename: Marc
authors.initials: M
authors.lastname: Udina
authors.forename: Ricard
authors.initials: R
authors.lastname: Navinés
authors.forename: Lucile
authors.initials: L
authors.lastname: Capuron
authors.forename: Rocío
authors.initials: R
authors.lastname: Martín-Santos
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced*; D003863:Depression / Q000139:chemically induced*; D005221:Fatigue / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D054643:INDEL Mutation; D016898:Interferon-alpha / Q000009:adverse effects*; D015850:Interleukin-6 / Q000235:genetics*; D017354:Point Mutation; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D012701:Serotonin / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*
chemical_list: D000998:Antiviral Agents; C508600:IL6 protein, human; D016898:Interferon-alpha; D015850:Interleukin-6; D011994:Recombinant Proteins; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D012701:Serotonin; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a